DHT: Notice of transaction of connected institution (ASKA PHARMACEUTICAL CO.,LTD.)
- Name of issuer: HaTay Pharmaceutical JSC - Stock code: DHT - Securities type: Common stock - Name of connected institution: ASKA PHARMACEUTICAL CO.,LTD. - Name of person discharging managerial responsibility (PDMR)/Director: Nishioka Hiroyasu - Position in the listed company: Member of the Board of Directors - Position in the trading institution: Representative of capital contribution - Number of shares held by person discharging managerial responsibility (PDMR)/Director: 0 shares (0%) - Name of person discharging managerial responsibility (PDMR)/Director: Oshio Keisuke - Position in the listed company: Member of the Board of Directors - Position in the trading institution: Representative of capital contribution - Number of shares held by person discharging managerial responsibility (PDMR)/Director: 0 shares (0%) - Number of shares held by connected institution before transaction: 27,721,778 shares (33.67%) - Number of shares to be acquired: 1,089,400 shares - Nature of transaction: Negotiation and order matching - Purpose of transaction: Increasing ownership at Ha Tay Pharmaceutical Joint Stock Company - Expected Start date of transaction: 27/02/2024 - Expected End date of transaction: 27/03/2024
HNX
> DHT: Result of transaction of connected institution (ASKA PHARMACEUTICAL CO.,LTD.) (26/02/2024)
> PRC: Notice of transaction of connected person (Le Quoc Dung) (26/02/2024)
> PRC: Notice of transaction of connected person (Le Thi Anh) (26/02/2024)
> PRC: Notice of transaction of Directors, PDMR (Le Nam Hung) (26/02/2024)
> PRC: Notice of transaction of connected person (Doan Thi Lien Huong) (26/02/2024)
> MCH: Result of transaction of Directors, PDMR (Huynh Viet Thang) (26/02/2024)
> SHS: Notice of transaction of Directors, PDMR (Do Quang Vinh) (26/02/2024)
> MSB: Notification affiliated person trade (26/02/2024)
> REE: Notification affiliated person trade - Platinum Victory (26/02/2024)
> ST8: Report on the day nolonger being major shareholders - Liu Dang Khoa (26/02/2024)